Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2671093 | 0.92 | DNM1 (0.45) | DNM1CA1CA2LPAR1LPAR3 | |
| SCHEMBL2670811 | 0.90 | DNM1 (0.48) | DNM1CA1CA2ZDHHC7LPAR1 | |
| SCHEMBL2670936 | 0.90 | CYP3A4 (0.39) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL2670949 | 0.87 | ZDHHC7 (0.41) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL7339342 | 0.85 | ZDHHC7 (0.44) | DNM1TSHRZDHHC7LCKPPARD | |
| SCHEMBL7337862 | 0.85 | ZDHHC7 (0.44) | DNM1TSHRZDHHC7LCKPPARD | |
| SCHEMBL4398367 | 0.84 | TSHR (0.37) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL2671071 | 0.83 | — | — | |
| SCHEMBL5961100 | 0.83 | ALDH1A1 (0.33) | ALDH1A1LMNA | |
| SCHEMBL4391336 | 0.83 | ADRB2 (0.34) | CYP3A4ADRB2ADRB1ADRB3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4374877-A2 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-29 | — | — | EP | disclosed |
| US-11932715-B2 | Hardmask composition and method of forming patterns | SAMSUNG SDI CO., LTD. (KR) | 2024-03-19 | — | — | US | disclosed |
| EP-3928779-B1 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2024-03-06 | — | — | EP | disclosed |
| US-11814393-B2 | Substituted guanidine compounds | UBE CORPORATION (JP) | 2023-11-14 | — | — | US | disclosed |
| CN-114660897-A | Hardmask composition and method of forming pattern | 三星SDI株式会社 | 2022-06-24 | — | — | CN | disclosed |
| US-20220195082-A1 | HARDMASK COMPOSITION AND METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2022-06-23 | — | — | US | disclosed |
| CN-110114350-B | Substituted guanidine compounds | 宇部兴产株式会社 | 2022-03-04 | — | — | CN | disclosed |
| EP-3564230-B1 | SUBSTITUTED GUANIDINE COMPOUND | UBE INDUSTRIES (JP) | 2022-02-09 | — | — | EP | disclosed |
| EP-3928779-A1 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. | Chugai Seiyaku Kabushiki Kaisha (JP) | 2021-12-29 | — | — | EP | disclosed |
| EP-3192511-B1 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2021-07-14 | — | — | EP | disclosed |
| EP-0226641-B1 | OXODIAZINE COMPOUNDS | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1989-10-18 | — | — | EP | disclosed |
| US-4840951-A | ANTILIPEMIC AGENTS | TANABE SEIYAKU CO., LTD. (JP) | 1989-06-20 | — | — | US | disclosed |
| EP-0251315-A2 | Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing the same | TANABE SEIYAKU CO., LTD. (JP) | 1988-01-07 | — | — | EP | disclosed |
| US-4713381-A | ANTICOAGULANTS, ANALGESICS, ANTIINFLAMMATORY AGENT | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1987-12-15 | — | — | US | disclosed |
| EP-0226641-A1 | OXODIAZINE COMPOUNDS. | YOSHITOMI PHARMACEUTICAL (JP) | 1987-07-01 | — | — | EP | disclosed |
| WO-1986007059-A2 | OXODIAZINE COMPOUNDS | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1986-12-04 | — | — | WO | disclosed |
| EP-0028137-B1 | DRY PLANOGRAPHIC PRINTING PLATE | TORAY INDUSTRIES, INC. (JP) | 1984-12-05 | — | — | EP | disclosed |
| US-4308799-A | POLYSILOXANE, ALKOXYSILANE, AND ORGANOTITANIUM OR ZIRCONIUM COMPOUND | TORAY INDUSTRIES, INC. (JP) | 1982-01-05 | — | — | US | disclosed |
| EP-0028137-A1 | Dry planographic printing plate | TORAY INDUSTRIES, INC. (JP) | 1981-05-06 | — | — | EP | disclosed |
| US-3988142-A | Increasing carbohydrate deposition in plants with N-phosphono-methylglycine and derivatives thereof | MONSANTO COMPANY (US) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814393-B2 | Substituted guanidine compounds | GMPS, PDE3B, GUCY1A2 | CYP3A4 302/4885ADRB2 233/4885ADRB1 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.